Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP291723.RAhXKrqzOJ80XvdyUjzYfIkEuLokNz0WL086IBGqrGix4130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291723.RAhXKrqzOJ80XvdyUjzYfIkEuLokNz0WL086IBGqrGix4130_provenance.
• NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262929.RAsGShkuV8jaKS0IYt4QYgMKoCUJNo3rS9EU4q5D0gdsY130_provenance.
• NP448954.RAl-NhyOtW-I7i-unzBLKdA2VzZzt76kA5Kd1RRqjsH9s130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP448954.RAl-NhyOtW-I7i-unzBLKdA2VzZzt76kA5Kd1RRqjsH9s130_provenance.
• NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831239.RAtycoEVbpZ4QicpEmPb8GzNWFdVlNJMuKgpmlPtbYp74130_provenance.
• NP205994.RAHwYiggnKfIWDaHI6LYyFxCFZh4jE9_7CJOM9BRU2Xi0130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP205994.RAHwYiggnKfIWDaHI6LYyFxCFZh4jE9_7CJOM9BRU2Xi0130_provenance.
• assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978534.RAlO-GwvwQPFi8SIHsKyp1h3cwEugn88zYAtaAqjwAqTo130_provenance.
• NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP357743.RAyIcHrdgVA5lJ-ch48olZqhTHmchLH5xZ2a87oxtQV4g130_provenance.
• NP388800.RAP6ZrqexkbIwaVNTrX3t4_8oQBCKoRTPR4etzD4rnqVg130_assertion description "[Aberrant differentiation in MDS can often be traced to abnormal DNA methylation (both gains and losses of DNA methylation genome wide and at specific loci) as well as mutations in genes that regulate epigenetic programs (TET2 and DNMT3a, both involved in DNA methylation control; EZH2 and ASXL1, both involved in histone methylation control).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388800.RAP6ZrqexkbIwaVNTrX3t4_8oQBCKoRTPR4etzD4rnqVg130_provenance.